Didrik F. Vestrheim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Didrik F. Vestrheim has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Ingeborg S. Aaberge
Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
5 shared publicationsDominique A. Caugant
Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway
4 shared publicationsE. Arne Høiby
Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway
2 shared publicationsMarianne R. Bergsaker
Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway
2 shared publicationsMartin Steinbakk
Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway
2 shared publicationsA. L. Wester
Division of Infectious Disease Control,Norwegian Institute of Public Health,Oslo,Norway
1 shared publication
Latest Publications
- Open Access
- 2 April 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (4) , 742
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveillance was represented from all geographic regions but was limited from lower income and high-burden countries. In PSERENADE, 18 sites evaluated PCV10, 42 PCV13, and 17 both; 17 sites used a 3 + 0 schedule, 38 used 2 + 1, 13 used 3 + 1, and 9 used mixed schedules. With such a sizeable and generally representative dataset, PSERENADE will be able to conduct robust analyses to estimate PCV impact and inform policy at national and global levels regarding adult immunization, schedule, and product choice, including for higher valency PCVs on the horizon.
- 2 April 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (4) , 742
Open AccessGlobal Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveillance was represented from all geographic regions but was limited from lower income and high-burden countries. In PSERENADE, 18 sites evaluated PCV10, 42 PCV13, and 17 both; 17 sites used a 3 + 0 schedule, 38 used 2 + 1, 13 used 3 + 1, and 9 used mixed schedules. With such a sizeable and generally representative dataset, PSERENADE will be able to conduct robust analyses to estimate PCV impact and inform policy at national and global levels regarding adult immunization, schedule, and product choice, including for higher valency PCVs on the horizon.
- Open Access
- 28 June 2018
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 6 (26)
Draft Genome Sequence of a Potentially Novel Streptococcus Species Belonging to the Streptococcus mitis Group
We report here the draft genome sequence of a Streptococcus species belonging to the S. mitis group. While a clear species identification cannot be made for the isolate, it appears that its most recent common ancestor is the species S. pseudopneumoniae .
- 28 June 2018
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 6 (26)
Open AccessDraft Genome Sequence of a Potentially Novel Streptococcus Species Belonging to the Streptococcus mitis Group
We report here the draft genome sequence of a Streptococcus species belonging to the S. mitis group. While a clear species identification cannot be made for the isolate, it appears that its most recent common ancestor is the species S. pseudopneumoniae .
- Open Access
- 21 August 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (14/15)
HPV-vaksinene gir god beskyttelse
Kommentar - Folkehelseinstituttet har nylig gjennomført anbudskonkurranse for HPV-vaksine til jenter i 7.
- 21 August 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (14/15)
Open AccessHPV-vaksinene gir god beskyttelse
Kommentar - Folkehelseinstituttet har nylig gjennomført anbudskonkurranse for HPV-vaksine til jenter i 7.
- 1 July 2016
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 7 (5) , 698-702
Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011–2013
- 1 July 2016
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 7 (5) , 698-702
Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011–2013
- 20 November 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 144 (8) , 1756-1760
Are ready-to-eat salads ready to eat? An outbreak of Salmonella Coeln linked to imported, mixed, pre-washed and bagged salad, Norway, November 2013
SUMMARY: We investigated a nationwide outbreak of Salmonella Coeln in Norway, including 26 cases identified between 20 October 2013 and 4 January 2014. We performed a matched case-control study, environmental investigation and detailed traceback of food purchases to identify the source of the outbreak. In the case-control study, cases were found to be more likely than controls to have consumed a ready-to-eat salad mix (matched odds ratio 20, 95% confidence interval 2·7–∞). By traceback of purchases one brand of ready-to-eat salad was indicated, but all environmental samples were negative for Salmonella. This outbreak underlines that pre-washed and bagged salads carry a risk of infection despite thorough cleaning procedures by the importer. To further reduce the risk of infection by consumption of ready-to-eat salads product quality should be ensured by importers. Outbreaks linked to salads reinforce the importance of implementation of appropriate food safety management systems, including good practices in lettuce production.
- 20 November 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 144 (8) , 1756-1760
Are ready-to-eat salads ready to eat? An outbreak of Salmonella Coeln linked to imported, mixed, pre-washed and bagged salad, Norway, November 2013
SUMMARY: We investigated a nationwide outbreak of Salmonella Coeln in Norway, including 26 cases identified between 20 October 2013 and 4 January 2014. We performed a matched case-control study, environmental investigation and detailed traceback of food purchases to identify the source of the outbreak. In the case-control study, cases were found to be more likely than controls to have consumed a ready-to-eat salad mix (matched odds ratio 20, 95% confidence interval 2·7–∞). By traceback of purchases one brand of ready-to-eat salad was indicated, but all environmental samples were negative for Salmonella. This outbreak underlines that pre-washed and bagged salads carry a risk of infection despite thorough cleaning procedures by the importer. To further reduce the risk of infection by consumption of ready-to-eat salads product quality should be ensured by importers. Outbreaks linked to salads reinforce the importance of implementation of appropriate food safety management systems, including good practices in lettuce production.
- 1 December 2012
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (12) , 4114-4115
Recovery of Bordetella pertussis from PCR-Positive Nasopharyngeal Samples Is Dependent on Bacterial Load
Viable Bordetella pertussis isolates are essential for surveillance purposes. We performed culture of 223 PCR-positive nasopharyngeal samples. B. pertussis was recovered from 45 (20.2%) of the samples. Growth was associated with a high bacterial load, as determined by PCR. Culture from PCR-positive samples is a feasible approach to recover B. pertussis isolates, and culture can be limited to samples with a high bacterial load.
- 1 December 2012
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (12) , 4114-4115
Recovery of Bordetella pertussis from PCR-Positive Nasopharyngeal Samples Is Dependent on Bacterial Load
Viable Bordetella pertussis isolates are essential for surveillance purposes. We performed culture of 223 PCR-positive nasopharyngeal samples. B. pertussis was recovered from 45 (20.2%) of the samples. Growth was associated with a high bacterial load, as determined by PCR. Culture from PCR-positive samples is a feasible approach to recover B. pertussis isolates, and culture can be limited to samples with a high bacterial load.
- 11 January 2012
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (3) , 443-445
Postvaccination Increase in Serotype 19A Pneumococcal Disease in Norway Is Driven by Expansion of Penicillin-Susceptible Strains of the ST199 Complex
Serotype replacement in invasive pneumococcal disease has been observed after widespread use of the 7-valent pneumococcal conjugate vaccine (PCV7). Replacement is dominated by penicillin-nonsusceptible serotype 19A in several countries. Antibiotic selection pressure has been proposed to interact with immunization, leading to rapid replacement. In Norway, where prescription of antibiotics is limited, post-PCV7 replacement by serotype 19A is dominated by penicillin-susceptible clones. Hence, serotype 19A replacement occurs, although it is not driven by antibiotic selection pressure.
- 11 January 2012
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (3) , 443-445
Postvaccination Increase in Serotype 19A Pneumococcal Disease in Norway Is Driven by Expansion of Penicillin-Susceptible Strains of the ST199 Complex
Serotype replacement in invasive pneumococcal disease has been observed after widespread use of the 7-valent pneumococcal conjugate vaccine (PCV7). Replacement is dominated by penicillin-nonsusceptible serotype 19A in several countries. Antibiotic selection pressure has been proposed to interact with immunization, leading to rapid replacement. In Norway, where prescription of antibiotics is limited, post-PCV7 replacement by serotype 19A is dominated by penicillin-susceptible clones. Hence, serotype 19A replacement occurs, although it is not driven by antibiotic selection pressure.
- 1 October 2011
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 11 (7) , 1703-1708
Pherotypes of pneumococcal strains co-existing in healthy children
- 1 October 2011
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 11 (7) , 1703-1708
Pherotypes of pneumococcal strains co-existing in healthy children